chlorpromazine has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Chlorpromazine: The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup.
chlorpromazine : A substituted phenothiazine in which the ring nitrogen at position 10 is attached to C-3 of an N,N-dimethylpropanamine moiety.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fujiwara, R | 1 |
Taniguchi, Y | 1 |
Rai, S | 1 |
Iwata, Y | 1 |
Fujii, A | 1 |
Fujimoto, K | 1 |
Kumode, T | 1 |
Serizawa, K | 1 |
Morita, Y | 1 |
Espinoza, JL | 1 |
Tanaka, H | 1 |
Hanamoto, H | 1 |
Matsumura, I | 1 |
1 other study available for chlorpromazine and Carcinoma, Non-Small Cell Lung
Article | Year |
---|---|
Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells.
Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Chlorpromazine; Drug Resistance, Neopla | 2022 |